Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells

Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells

The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has an enormous impact on human health and economy. In search for therapeutic options, researchers have proposed resveratrol, a food supplement with known antiviral, anti-inflammatory, and ant...

Full description

Bibliographic Details
Main Authors: Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P.I. van de Pol, Heidi H. van der Ende-Metselaar, Leonie Apperloo, Djoke van Gosliga, Maarten van den Berge, Martijn C. Nawijn, Peter H.J. van der Voort, Jill Moser, Izabela A. Rodenhuis-Zybert, Jolanda M. Smit
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Viruses
Subjects:
resveratrol
pterostilbene
SARS-CoV-2
antiviral
human primary bronchial epithelial cells
Online Access:https://www.mdpi.com/1999-4915/13/7/1335

Internet

https://www.mdpi.com/1999-4915/13/7/1335

Similar Items